Fluorescent In Situ Hybridization As a Primary Test for HER2 Status in Breast Cancer: Controversies Reply

被引：4
|
作者：
Sauter, Guido [1 ]
Lee, James A. [2 ]
Slamon, Dennis J. [3 ]
Press, Michael F. [4 ,5 ]
机构：
[1] Univ Hamburg, Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany
[2] Altarum Inst, Ann Arbor, MI USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Keck Sch Med, Dept Pathol, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90095 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 05期
关键词：
COST-EFFECTIVENESS ANALYSIS; RECEPTOR; 2; ASSESSMENT; GENE AMPLIFICATION; IMMUNOHISTOCHEMICAL ASSAY; FISH; TRASTUZUMAB; CONCORDANCE; CARCINOMAS; EXPRESSION; HERCEPTEST;
D O I：
10.1200/JCO.2009.25.3930
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E85 / E88
页数：4
相关论文
共 50 条
  • [1] Fluorescent In Situ Hybridization As a Primary Test for HER2 Status in Breast Cancer: Controversies
    Arena, Vincenzo
    Pennacchia, Ilaria
    Monego, Giovanni
    Carbone, Arnaldo
    Capelli, Arnaldo
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) : E83 - E84
  • [2] Fluorescent In Situ Hybridization for Human Epidermal Growth Factor Receptor 2 Assessment in Breast Cancer: Is It Applicable As a Primary Test? Reply
    Sauter, Guido
    Lee, James
    Bartlett, John M. S.
    Slamon, Dennis J.
    Press, Michael F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) : E9 - E10
  • [3] Determination of the HER2 amplification status by in situ fluorescent hybridization and concordance with immunohistochemistry for breast cancer samples in Colombia
    Plata, Adriana
    Torres, Maria Mercedes
    Lopez, Rocio
    Andrade, Rafael E.
    COLOMBIA MEDICA, 2013, 44 (02): : 108 - 114
  • [4] Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer
    Stocker, Albina
    Trojan, Andreas
    Elfgen, Constanze
    Hilbers, Marie-Louis
    Moskovszky, Linda
    Varga, Zsuzsanna
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (02) : 311 - 319
  • [5] Correlation of In Situ HER2 RNA Expression With HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Categories in Breast Cancer
    Tseng, Yu-Fen
    Li, Yu-Chia
    Lee, Yi-Hsuan
    Hu, Hsiang-We
    Zhang, Man-San
    Hung, Tze-Chun
    Lien, Huang-Chun
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (03) : e48 - e56
  • [6] Detection of ERBB2 and CEN17 signals in fluorescent in situ hybridization and dual in situ hybridization for guiding breast cancer HER2 target therapy
    Wang, Ching-Wei
    Khalil, Muhammad-Adil
    Lin, Yi-Jia
    Lee, Yu-Ching
    Chao, Tai-Kuang
    ARTIFICIAL INTELLIGENCE IN MEDICINE, 2023, 141
  • [7] Droplet digital polymerase chain reaction offers an improvisation over conventional immunohistochemistry and fluorescent in situ hybridization for ascertaining Her2 status of breast cancer
    Suryavanshi, Moushumi
    Jaipuria, Jiten
    Mehta, Anurag
    Kumar, Dushyant
    Panigrahi, Manoj Kumar
    Verma, Haristuti
    Saifi, Mumtaz
    Sharma, Sanjeev
    Tandon, Simran
    Doval, Dinesh Chandra
    Das, Bhudev C.
    SOUTH ASIAN JOURNAL OF CANCER, 2019, 8 (04) : 203 - +
  • [8] Whether to determine HER2 status for breast cancer in the primary tumour or in the metastasis
    Santiago, M. P.
    Vazquez-Boquete, A.
    Fernandez, B.
    Masa, C.
    Antunez, J. R.
    Fraga, M.
    Forteza, J.
    Garcia-Caballero, T.
    HISTOLOGY AND HISTOPATHOLOGY, 2009, 24 (06) : 675 - 682
  • [9] Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program
    Bilous, Michael
    Morey, Adrienne L.
    Armes, Jane E.
    Bell, Richard
    Button, Peter H.
    Cummings, Margaret C.
    Fox, Stephen B.
    Francis, Glenn D.
    Waite, Brigid
    McCue, Glenda
    Raymond, Wendy A.
    Robbins, Peter D.
    Farshid, Gelareh
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 617 - 624
  • [10] Concordance of HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Using Tissue Microarray in Breast Cancer
    Furrer, Daniela
    Jacob, Simon
    Caron, Chantal
    Sanschagrin, Francois
    Provencher, Louise
    Diorio, Caroline
    ANTICANCER RESEARCH, 2017, 37 (06) : 3323 - 3329
12345